Arowor Corp. is a rarefied preclinical-stage biotechnology startup working at the trinary manifolds of biology, chemistry, and physics, intersecting the basic, fundamental, and applied sciences. Its effort is to commercialize its discoveries and inventions leading predominantly to regulated biopharmaceutical offerings for serious unmet medical conditions. The corporation currently manages portfolio development and will also pioneer forthcoming regulatory approvals and manufacturing; future industrial partnership will result in distribution and marketing. The core business success concepts are scientific stringency, computational intervention, emergent scalability, and data-based forecasting.
Aron Workman is a scientist, inventor, and developer. His extracorporate fundamental discoveries include that superoxide radical is the primary catalyst of combustion and ignition, discovery of the neural annealer of the human neocortex, and discoveries on radicalized chemoelectric signal intelligence transduction. Workman holds a B.S. in Chemistry & Neurobiology, summa c. laude, and an M.S. in Pharmacy forthcoming this summer, University of Florida.
Aron Workman, Chief Executive Officer
Aron Workman, Chairman
Under formation by invitation.